24. Shamji MH, Kappen JH, Akdis M et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017;72:1156—1173.
25. Pulendran B, Tang H, Manicassamy S. Programming dendritic cells to induce T (H) 2 and tolerogenic responses. Nat Immunol. 2010;11 (8):647—655.
26. Gordon JR, Ma Y, Churchman L, Gordon SA, Dawicki W. Regulatory dendritic cells for immunotherapy in immunologic diseases. Front Immunol. 2014;5:7.
27. Sun W, Wei JW, Li H, Wei FQ, Li J, Wen WP. Adoptive cell therapy of tolerogenic dendritic cells as inducer of regulatory T cells in allergic rhinitis. International forum of allergy & rhinology. 2018;8 (11):1291—1299.
28. Tanaka Y, Nagashima H, Bando K et al. Oral CD103 (-) CD11b (+) classical dendritic cells present sublingual antigen and induce Foxp3 (+) regulatory T cells in draining lymph nodes. Mucosal Immunol. 2017;10:79—90.
29. Deniz G, Akdis M, Aktas E, Blaser K, Akdis CA. Human NK1 and NK2 subsets determined by purification of IFN-gammasecreting and IFN-gamma-nonsecretingNK cells. Eur J Immunol. 2002;32 (3):879—884.
30. Deniz G, Erten G, Kucuksezer UC, et al. Regulatory NK cells suppress antigenspecific T cell responses. J Immunol. 2008;180 (2):850—857.
31. Ferstl R, Frei R, Barcik W, et al. Histamine receptor 2 modifies iNKT cell activity within the inflamed lung. Allergy. 2017;72 (12):1925—1935.
32. Globinska A, Kowalski ML. Innate lymphoid cells: the role in respiratory infections and lung tissue damage. Exp Rev Clin Immunol. 2017;13 991—999.
33. Kortekaas Krohn I, Shikhagaie MM, Golebski K, et al. Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications. Allergy. 2018;73 (4):837—850.
34. Lao-Araya M, Steveling E, Scadding GW, Durham SR, Shamji MH. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol. 2014;134 (5):1193—1195.
35. Fan DC, Wang XD, Wang CS, Wang Y, Cao FF, Zhang L. Suppression of immunotherapy on group 2 innate lymphoid cells in allergic rhinitis. Chin Med J (Engl). 2016;129:2824—2828.
36. Morita H, Kubo T, Ruckert B, et al. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. J Allergy Clin Immunol. 2019;143:2190—2201.